WHO approves world's first malaria vaccine, which kills hundreds of thousands of children each year
The World Health Organization has approved the widespread use of the world's first malaria vaccine. This was reported on the organization's website. The latest phase of trials of the vaccine, marketed under the brand name Mosquirix, has been ongoing since 2019, involving more than 800,000 children in Ghana, Kenya and Malawi. The vaccine showed limited effectiveness, preventing infection in only 39% of cases and reducing the likelihood of severe disease by 29%.